Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108. https://doi.org/10.3322/canjclin.55.2.74. (In eng).

Article  PubMed  Google Scholar 

Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450–62. https://doi.org/10.1056/NEJMra1713263. (In Eng).

Article  CAS  PubMed  Google Scholar 

Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology. 2014;272(3):635–54. https://doi.org/10.1148/radiol.14132361. (In eng).

Article  PubMed  Google Scholar 

Akinyemiju T, Abera S, Ahmed M, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015. JAMA. Oncol. 2017;3(12):1683–91. https://doi.org/10.1001/jamaoncol.2017.3055. (In eng).

Article  Google Scholar 

Navin PJ, Venkatesh SK. Hepatocellular carcinoma: state of the art imaging and recent advances. J Clin Transl Hepatol. 2019;7(1):72–85. https://doi.org/10.14218/jcth.2018.00032. (In eng).

Article  PubMed  PubMed Central  Google Scholar 

Younossi Z, Stepanova M, Ong JP, et al. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol. 2019;17(4):748-755.e3. https://doi.org/10.1016/j.cgh.2018.05.057. (In eng).

Article  PubMed  Google Scholar 

Theise ND CM, Franceschi S, et al. Hepatocellular carcinoma. WHO Classification of Tumours of the Digestive System 2010;4th ed. Lyon, France: IARC, 2010; 205–216.

Roskams T, Kojiro M. Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis. Semin Liver Dis. 2010;30(1):17–25. https://doi.org/10.1055/s-0030-1247129. (In eng).

Article  PubMed  Google Scholar 

Garuti F, Neri A, Avanzato F, Gramenzi A, Rampoldi D, Rucci P, Farinati F, Giannini EG, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Missale G, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Brunetto MR, Trevisani F. ITA.LI.CA study group. The changing scenario of hepatocellular carcinoma in Italy: an update. Liver Int. 2021Mar;41(3):585–97. https://doi.org/10.1111/liv.14735. Epub 2020 Dec 2. PMID: 33219585.

Article  PubMed  Google Scholar 

Trevisani F, Cantarini MC, Wands JR, Bernardi M. Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis. 2008;29(7):1299–305. https://doi.org/10.1093/carcin/bgn113. (In eng).

Article  CAS  PubMed  Google Scholar 

Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology. 2000;31(2):330–5. https://doi.org/10.1002/hep.510310211. (In eng).

Article  CAS  PubMed  Google Scholar 

Trevisani F, De Notariis S, Rapaccini G, et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol. 2002;97(3):734–44. https://doi.org/10.1111/j.1572-0241.2002.05557.x. (In eng).

Article  PubMed  Google Scholar 

McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis. 2005;25(Suppl 1):3–8. https://doi.org/10.1055/s-2005-915644. (In eng).

Article  PubMed  Google Scholar 

Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology. 2014;273(1):30–50. https://doi.org/10.1148/radiol.14132362. (In eng).

Article  PubMed  Google Scholar 

Takeda H, Takai A, Eso Y, Takahashi K, Marusawa H, Seno H. Genetic landscape of multistep hepatocarcinogenesis. Cancers (Basel). 2022;14(3):568. https://doi.org/10.3390/cancers14030568.PMID:35158835;PMCID:PMC8833551.

Article  CAS  PubMed  Google Scholar 

Tomizawa M, Kondo F, Kondo Y. Growth patterns and interstitial invasion of small hepatocellular carcinoma. Pathol Int. 1995;45(5):352–8. https://doi.org/10.1111/j.1440-1827.1995.tb03468.x. (In eng).

Article  CAS  PubMed  Google Scholar 

Kojiro M. Histopathology of liver cancers. Best Pract Res Clin Gastroenterol. 2005;19(1):39–62. https://doi.org/10.1016/j.bpg.2004.10.007. (In eng).

Article  PubMed  Google Scholar 

Stevens WR, Gulino SP, Batts KP, Stephens DH, Johnson CD. Mosaic pattern of hepatocellular carcinoma: histologic basis for a characteristic CT appearance. J Comput Assist Tomogr. 1996;20(3):337–42. https://doi.org/10.1097/00004728-199605000-00001. (In eng).

Article  CAS  PubMed  Google Scholar 

Ueda K, Matsui O, Kawamori Y, et al. Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography. Radiology. 1998;206(1):161–6. https://doi.org/10.1148/radiology.206.1.9423667. (In eng).

Article  CAS  PubMed  Google Scholar 

Jang YR, Lee KW, Kim H, Lee JM, Yi NJ, Suh KS. Bile duct invasion can be an independent prognostic factor in early stage hepatocellular carcinoma. Kor J Hepatobiliary Pancreat Surg. 2015;19(4):167–72. https://doi.org/10.14701/kjhbps.2015.19.4.167. (In Eng).

Article  Google Scholar 

Yang X, Qiu Z, Ran R, et al. Prognostic importance of bile duct invasion in surgical resection with curative intent for hepatocellular carcinoma using PSM analysis. Oncol Lett. 2018;16(3):3593–602. https://doi.org/10.3892/ol.2018.9108.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ikenaga N, Chijiiwa K, Otani K, Ohuchida J, Uchiyama S, Kondo K. Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion. J Gastrointest Surg. 2009;13(3):492–7. https://doi.org/10.1007/s11605-008-0751-0. (In eng).

Article  PubMed  Google Scholar 

Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 2014;11(4):e1001624. https://doi.org/10.1371/journal.pmed.1001624. (In eng).

Article  PubMed  PubMed Central  Google Scholar 

Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, Rigamonti A, Barbara C, Grigioni W, Mazziotti A, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology. 1992;16(1):132–7. https://doi.org/10.1002/hep.1840160122. PMID: 1352268.

Article  CAS  PubMed  Google Scholar 

Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M. HCC Expert Panel of Japan Society of Hepatology. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis. 2011;29(3):339–64. https://doi.org/10.1159/000327577. Epub 2011 Aug 9. PMID: 21829027.

Article  PubMed  Google Scholar 

Trinchet JC, Chaffaut C, Bourcier V, Degos F, Henrion J, Fontaine H, Roulot D, Mallat A, Hillaire S, Cales P, Ollivier I, Vinel JP, Mathurin P, Bronowicki JP, Vilgrain V, N’Kontchou G, Beaugrand M, Chevret S, Groupe d’Etude et de Traitement du Carcinome Hépatocellulaire (GRETCH). Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities. Hepatology. 2011;54(6):1987–97. https://doi.org/10.1002/hep.24545. PMID: 22144108.

Article  PubMed  Google Scholar 

Tzartzeva K, Obi J, Rich NE, et al. Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis. Gastroenterology. 2018;154(6):1706-1718.e1. https://doi.org/10.1053/j.gastro.2018.01.064.

Article  CAS  PubMed  Google Scholar 

Kim SY, An J, Lim YS, et al. MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma. JAMA Oncol. 2017;3(4):456–63. https://doi.org/10.1001/jamaoncol.2016.3147. (In eng).

Article  PubMed  PubMed Central  Google Scholar 

Park HJ, Kim SY. Imaging modalities for hepatocellular carcinoma surveillance: expanding horizons beyond ultrasound. J Liver Cancer. 2020;20(2):99–105. https://doi.org/10.17998/jlc.20.2.99.

Article  PubMed  PubMed Central  Google Scholar 

Bansal S, Lu F, Frehlich L, Wong JK, Burak KW, Wilson SR. Correction to: A new proposal for secondary surveillance following potentially curative therapy of HCC: alternating MRI and CEUS. Abdom Radiol (NY). 2022;47(3):1207. https://doi.org/10.1007/s00261-021-03385-1.